肺癌
医学
肿瘤科
突变体
内科学
癌症研究
生物
基因
遗传学
作者
Si‐Yang Maggie Liu,Tatiana Erazo,Justin Jee,Andrea Arfè,Avantika Gupta,Luke Pike,Fernando C. Santini,Bobby Daly,Adam J. Schoenfeld,Jordan Eichholz,Kaylie Johnson,Andrés Martinez,Jane Sze Yin Sui,Nadeem Riaz,Jason C. Chang,Soo‐Ryum Yang,William D. Travis,Maria E. Arcila,Jiannan Guo,Éric Gagné
标识
DOI：10.1016/j.ejca.2024.114257
摘要
No definitive answers currently exist regarding optimal first-line therapy for HER2-mutant NSCLC. Access to rapid tissue sequencing is a major barrier to precision drug development in the first-line setting. ctDNA analysis has the potential to overcome these obstacles and guide treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
Criminology34
嘻嘻哈哈
zcl
GingerF
昏睡的蟠桃
sissiarno
lalala
七月流火
BowieHuang
浮游
修仙中
cc
遇上就这样吧
MchemG
shi hui
wlscj
小蜻蜓
GPTea
青蛙打不过小熊
小青椒
沉心静气搞学习
归尘
不倦
eric888
镓氧锌钇铀
star
山野有雾都
风清扬
皖公网安备34019202002308
